Minority-Based Community Clinical Oncology Program Groups

by: Iola Bonggay

The National Institutes of Health, more commonly referred to as NIH, is a federal government agency operating under the purview of the United States Department of Health and Human Services that is primarily responsible for supporting the nation's biomedical and health-related research studies.

The grants and programs of the NIH are all magnanimously engineered to assist in the realization of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In line with this mission, the National Institutes of Health has recently collaborated with the National Cancer Institute (NCI) in an attempt to establish the Minority-Based Community Clinical Oncology Program Groups (MBCCOP).

The primary purpose of the program is to support research initiatives involving physicians who are participating in the care of minorities and who are eligible to participate in NCI-sponsored cancer prevention, control, and treatment clinical trials.

In addition, the program also serves as an opportunity for practicing oncologists who serve large racial/ethnic minority populations to participate in clinical trials sponsored by the National Cancer Institute.

Essentially, this program is designed to cater to minority populations and to bring forth state-of-the-art cancer clinical trials to minority individuals in their own communities.

  (continued...)

Minority-Based Community Clinical Oncology Program Groups
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Environmental Exposures and Health: Exploration of Non-Traditional Settings Program
In according with this mission, the National Institutes of Health has partnered with the National Institute of Nursing Research (NINR) and the National Institute of Environmental Health Sciences (NIEHS) to establish the Environmental Exposures and Health: Exploration of Non-Traditional Settings Program.

---

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

---

Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program
The Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.

---